Tuesday, April 16, 2019





Catalent to Acquire Paragon Bioservices for $1.2B, Expanding #Gene_Therapy Capabilities


International #Conference on #Genetic_Disorders and  #Gene_Therapy
#August 26-27, 2019 #Bangkok#Thailand
Theme: Current research and futuristic challenges in Genetics


Visit us at  https://genetics.geneticconferences.com/




Catalent to Acquire Paragon Bioservices for $1.2B, Expanding Gene Therapy Capabilities


Catalent said today it has agreed to acquire Paragon Bioservices for $1.2 billion cash, in a deal designed to expand the buyer’s capabilities into the gene therapy field with a leading developer and manufacturer of viral vectors.

Based at University of Maryland (UM) BioPark in Baltimore, on the academic medical center campus of the University of Maryland, Baltimore (UMB), private equity-backed Paragon is a contract development and manufacturing organization (CDMO) focused on gene therapies delivered via adeno-associated virus (AAV) vectors, as well as next-generation vaccines, oncology immunotherapies (oncolytic viruses), and other complex biologics.
According to Paragon’s website, 50% of its current contracts are for gene therapy work. Paragon says it has helped develop and manufacture more than 50 different biotherapeutics and vaccines with its clients over the past 25 years.
Both companies have been in expansion mode. On Thursday, Paragon officially marked the opening of a new 200,000-square-foot facility in Harmans, Anne Arundel County, near Baltimore/Washington Thurgood Marshall International Airport. That facility—equipped with several 500 L and 2000 L single-use bioreactors for clinical through commercial material production—is expected to boost Paragon’s workforce to more than 500 people by year’s end, including the 350+ now based at UM BioPark.
A day earlier, Catalent held a ceremony marking the completion of a new 30,000-square-foot clinical supply facility in Shanghai. The new facility, expected to employ up to 100 people, offers clinical supply services including FastChain® demand-led supply, secondary packaging, clinical storage, and local distribution, as well as clinical returns and destruction services. The facility is located outside the free trade zone (FTZ) in Tangzhen, near Catalent’s existing Waigaoqiao FTZ site and China’s Shanghai Zhangjiang National Innovation Demonstration Zone, dubbed “Medicine Valley” by authorities since biopharma is among its pillar industries.

Monday, April 15, 2019






#Specially-adapted bikes donated to Washington kids with #genetic_disorders

International #Conference on #Genetic_Disorders and #Gene_Therapy#August 26-27, 2019 #Bangkok#ThailandTheme: Current research and futuristic challenges in Genetics

visit us at  https://genetics.geneticconferences.com/Email us at  genetics@asiameetings.org



Human genetics, a study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that in other organisms. Human Genetics incorporates an assortment of covering fields including classical genetics, cytogenetics, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic counseling. Genes can be the normal factor of the characteristics of most human-acquired attributes. Genomics is the study of whole genomes of organisms and incorporates components from biology. Genomics uses a combination of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. Genomics is to boot upset concerning the structure, capacity, examination, and advancement of genomes.

Friday, April 12, 2019




Single Dose of CRISPR Gene Therapy May Succeed as Long-term Treatment for DMD, Mouse Study Shows

International #Conference on #Genetic_Disorders and #Gene_Therapy#August 30-31, 2019 #Bangkok#ThailandTheme: Current research and futuristic challenges in GeneticsEmail us: genetics@asiameetings.orgWebsite: https://genetics.geneticconferences.com/


1. Genomics2. Human Genetics3. Genetic disorders4. Stem Cell Biology5. Genome Engineering6. Cancer Genomics7. Molecular and Cellular Genetics8. Medicinal Genetics9. Cytogenetics10. Neurogenetics11. Immunology & Immunogenetics12. Nutrigenetics
13. Epigenetics  14. Pharma Genomics & Pharma Informatics15. Genome Mapping16. Gene Therapy and Genetic Counselling17. Stem Cell research and Therapy18. Genomics Market19. Global Markets for Genetics & Genetic Disorders


Thursday, April 11, 2019



We invite all the participants across the world to attend the International Conference on Genetic Disorders and Gene Therapy during August 30-31, 2019 Bangkok, ThailandThe theme of the conference is “Current research and futuristic challenges in Genetics” and to encourage young minds and their research abilities by providing an opportunity to meet the experts in the field of Genetic Disorders. GENETICS &GENE THERAPY 2019
Gene therapy is a complex process involves incorporation of specific engineered genes into the affected cells where different kinds of viruses are used as vectors like retroviruses, adenoviruses, adeno-associated viruses, herpes simplex viruses. Genetics deals with gene sciences and its disorders. Genetics is an emerging group of sciences, which involves medicine, genetic engineering, and other biological sciences. Disorders in gene composition, called mutation may result in genetic disorders that need gene therapy treatment. Failure of treatment succeeds the mutant genes to offsprings causing hereditary diseases or disorders.
Why to attend Genetic Disorders Conference?
 Genetic Conferences 2018 anticipates hundreds of delegates including international keynote lectures and oral presentations by renowned speakers and poster presentations by students, Exhibitions, and delegates all around the world which will craft a platform for global promotion and effective development in this field. It provides international networking and opportunities for collaborations with worldwide companies and industries Genetic Disorders Meetings
This global event will be an excellent opportunity for the Genetic Disorders Scientists and other professionals. We are anticipating around 100+ speakers and over 200 delegates for this esteemed Congress. Genetics Conferences 2019 

Target Audience of Genetic Disorders Conference

  • CEO of Genetic companies
  • Directors Of Genetic companies
  • Co-Directors of Genetic companies
  • Researchers
  • Scientists
  • Bioinformaticians
  • Genetic engineers
  • Genetic counselors
  • Professors
  • Young Researchers 
  • Students
  • Technical Staff
  • Molecular biologists
  • Genetics Industries
  • Genetics Associations and Societies
  • Pharmaceutical companies

Conference Highlights:
•              Human Genetics and Genomics
•              Genetic Disorders
•              Gene Therapy and Genetic Counselling
•              Stem Cell Therapy
•              Stem Cell Biology
•              Genome Engineering
•              Thalassemia
•              Sickle Cell Anaemia
•              Genome Mapping
•              Cancer Genomics
•              Molecular and Cellular Genetics
•              Medicinal Genetics
•              Cytogenetics and Neurogenetics
•              Immunology and Immunogenetics
•              Nutrigenetics
•              Epigenetics
•              Pharmacogenomics
•              Genomics Market

Monday, January 28, 2019

GENETICS & GENE THERAPY 2019

About Conference


Conferenceseries LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. 

Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", Conferenceseries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology journals. Conferenceseries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. Conferenceseries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.


Special Issues


  •  All accepted abstracts will be published in respective Supporting International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.

Catalent to Acquire Paragon Bioservices for $1.2B, Expanding  #Gene_Therapy  Capabilities International  #Conference  on  #Genetic_...